ACTINIUM PHARMACEUTICALS, INC. Operating Lease, Expense
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Operating Lease, Expense of $218.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-08-07
- ACTINIUM PHARMACEUTICALS, INC. operating lease, expense for the quarter ending 2026-06-30 was $218.00K, a 26.01% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. operating lease, expense for the quarter ending 2026-03-31 was $218.00K, a 26.01% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. operating lease, expense for the quarter ending 2025-12-31 was $188.00K, a 9.30% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. operating lease, expense for the quarter ending 2025-09-30 was $173.00K, a 0.00% change year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. operating lease, expense for fiscal 2025 was $707.00K, a 2.32% increase from fiscal 2024.
- ACTINIUM PHARMACEUTICALS, INC. operating lease, expense for fiscal 2024 was $691.00K, a 0.00% change from fiscal 2023.
- ACTINIUM PHARMACEUTICALS, INC. operating lease, expense for fiscal 2023 was $691.00K, a 18.32% increase from fiscal 2022.
- ACTINIUM PHARMACEUTICALS, INC. operating lease, expense for fiscal 2022 was $584.00K, a 56.99% increase from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $218.00K 10-Q · filed 2026-08-07 | $437.00K 10-Q · filed 2026-08-07 | $624.00K derived: sum of 3 quarters · filed 2026-08-07 | $797.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $218.00K 10-Q · filed 2026-05-08 | $406.00K derived: sum of 2 quarters · filed 2026-05-08 | $579.00K derived: sum of 3 quarters · filed 2026-05-08 | $752.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $188.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $361.00K derived: sum of 2 quarters · filed 2026-03-30 | $534.00K derived: sum of 3 quarters · filed 2026-08-07 | $707.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $173.00K 10-Q · filed 2025-11-14 | $346.00K derived: sum of 2 quarters · filed 2026-08-07 | $519.00K 10-Q · filed 2025-11-14 | $691.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $173.00K 10-Q · filed 2026-08-07 | $346.00K 10-Q · filed 2026-08-07 | $518.00K derived: sum of 3 quarters · filed 2026-08-07 | $691.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $173.00K 10-Q · filed 2026-05-08 | $345.00K derived: sum of 2 quarters · filed 2026-05-08 | $518.00K derived: sum of 3 quarters · filed 2026-05-08 | $691.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $172.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $345.00K derived: sum of 2 quarters · filed 2026-03-30 | $518.00K derived: sum of 3 quarters · filed 2026-03-30 | $691.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $173.00K 10-Q · filed 2025-11-14 | $346.00K derived: sum of 2 quarters · filed 2025-11-14 | $519.00K 10-Q · filed 2025-11-14 | $692.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $173.00K 10-Q · filed 2025-08-08 | $346.00K 10-Q · filed 2025-08-08 | $519.00K derived: sum of 3 quarters · filed 2025-08-08 | $692.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $173.00K 10-Q · filed 2025-05-09 | $346.00K derived: sum of 2 quarters · filed 2025-05-09 | $519.00K derived: sum of 3 quarters · filed 2025-05-09 | $702.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $173.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $346.00K derived: sum of 2 quarters · filed 2025-03-31 | $529.00K derived: sum of 3 quarters · filed 2025-03-31 | $691.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $173.00K 10-Q · filed 2024-11-14 | $356.00K derived: sum of 2 quarters · filed 2024-11-14 | $518.00K 10-Q · filed 2024-11-14 | $662.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $183.00K 10-Q · filed 2024-08-05 | $345.00K 10-Q · filed 2024-08-05 | $489.00K derived: sum of 3 quarters · filed 2024-08-05 | $695.00K derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | $162.00K 10-Q · filed 2024-04-26 | $306.00K derived: sum of 2 quarters · filed 2024-04-26 | $512.00K derived: sum of 3 quarters · filed 2024-04-26 | $653.00K derived: sum of 4 quarters · filed 2024-04-26 |
| 2022-12-31 | $144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $350.00K derived: sum of 2 quarters · filed 2024-03-29 | $491.00K derived: sum of 3 quarters · filed 2024-03-29 | $584.00K 10-K · filed 2024-03-29 |
| 2022-09-30 | $206.00K 10-Q · filed 2023-11-02 | $347.00K derived: sum of 2 quarters · filed 2023-11-02 | $440.00K 10-Q · filed 2023-11-02 | $533.00K derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $141.00K 10-Q · filed 2023-08-14 | $234.00K 10-Q · filed 2023-08-14 | $327.00K derived: sum of 3 quarters · filed 2023-08-14 | $420.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $93.00K 10-Q · filed 2023-05-15 | $186.00K derived: sum of 2 quarters · filed 2023-05-15 | $279.00K derived: sum of 3 quarters · filed 2023-05-15 | $372.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $186.00K derived: sum of 2 quarters · filed 2023-03-31 | $279.00K derived: sum of 3 quarters · filed 2023-03-31 | $372.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $93.00K 10-Q · filed 2022-11-14 | $186.00K derived: sum of 2 quarters · filed 2022-11-14 | $279.00K 10-Q · filed 2022-11-14 | $372.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $93.00K 10-Q · filed 2022-08-12 | $186.00K 10-Q · filed 2022-08-12 | $279.00K derived: sum of 3 quarters · filed 2022-08-12 | $372.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $93.00K 10-Q · filed 2022-05-13 | $186.00K derived: sum of 2 quarters · filed 2022-05-13 | $279.00K derived: sum of 3 quarters · filed 2022-05-13 | $372.00K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $186.00K derived: sum of 2 quarters · filed 2022-03-25 | $279.00K derived: sum of 3 quarters · filed 2022-03-25 | $372.00K 10-K · filed 2022-03-25 |
| 2020-09-30 | $93.00K 10-Q · filed 2021-11-12 | $186.00K derived: sum of 2 quarters · filed 2021-11-12 | $279.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $93.00K 10-Q · filed 2021-07-30 | $186.00K 10-Q · filed 2021-07-30 | ||
| 2020-03-31 | $93.00K 10-Q · filed 2021-05-14 | |||
| 2019-09-30 | $93.00K 10-Q · filed 2020-10-23 | $279.00K 10-Q · filed 2020-10-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |